Vaccine News and Research

Latest Vaccine News and Research

Researchers report first randomized trial results of 'kick and kill' approach to treat HIV

Researchers have reported the results of the first randomized clinical trial to test a novel strategy involving waking up and then killing the 'sleeping' HIV that is hiding in the body using an experimental approach known as 'kick and kill'.

24 Jul 2018

New study provides important clues to developing more effective Ebola vaccines

Scientists conducting the first comprehensive study of key immune system cells - collected from West African Ebola survivors that kill Ebola infected cells have made a surprising discovery that provides important clues to developing effective vaccines against the infection.

24 Jul 2018

Outrage over China vaccines scandal

One of the largest vaccine manufacturers in China, Changchun Changsheng Bio-technology Ltd. was found to have falsified reports in connection with production and inspection of around 113,000 rabies vaccines.

23 Jul 2018

MOF vaccines could increase access to immunization and reduce the risk of global pandemics

Vaccinations are the safest way to protect against disease. However, many vaccines become ineffective when exposed to room temperature or heat.

23 Jul 2018

Studies highlight issues regarding black lung, opioid overdose, police violence and more

This study found the national prevalence of coal worker's pneumoconiosis (black lung) is increasing among working coal miners. In central Appalachia, 20.6 percent of miners working more than 25 years have black lung disease.

20 Jul 2018

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

AbbVie, a research-based global biopharmaceutical company, today announced it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for venetoclax in combination with a hypomethylating agent or in combination with low-dose cytarabine for the treatment of newly diagnosed patients with acute myeloid leukemia who are ineligible for intensive chemotherapy.

20 Jul 2018

New vaccine could protect unborn babies from Zika virus

Until recently, the Zika virus was not a priority since it affected relatively few people and the cost of creating a vaccine was estimated at EUR 149-468 million. But the spread of Zika in the Americas and discovery of a link with reduced head size and brain damage in babies of women infected while pregnant changed that.

20 Jul 2018

Researchers design proteins that can self-assemble into complex structures

A collaborative research team based in Japan has designed new proteins that can self-assemble into the complex structures underlying biological organisms, laying the groundwork for leading-edge applications in biotechnology.

20 Jul 2018

Researchers create vaccine that protects against malaria in mouse models

A Yale-led team of researchers have created a vaccine that protects against malaria infection in mouse models, paving the way for the development of a human vaccine that works by targeting the specific protein that parasites use to evade the immune system.

13 Jul 2018

Retooled vaccine raises hopes as a lower-cost treatment for Type 1 diabetes

For Hodalis Gaytan, 20, living with Type 1 diabetes means depending on an assortment of expensive medicines and devices to stay healthy. Test strips. Needles. A glucose meter. Insulin.

13 Jul 2018

Researchers develop novel approach to bridge gap in cell-free systems

Engineering cellular biology, minus the actual cell, is a growing area of interest in biotechnology and synthetic biology.

13 Jul 2018

Researchers decipher key component behind rising epidemic of pathogens in West Africa

A research team from several institutions being led by the University of California San Diego has deciphered a key component behind a rising epidemic of pathogens that the World Health Organization (WHO) recently added to its list of critical emerging diseases.

13 Jul 2018

Aeras announces publication of Phase 2 results of two TB vaccines

Aeras, a nonprofit organization dedicated to developing vaccines against tuberculosis (TB), today announced the publication of the full results from a Phase 2, randomized, controlled clinical trial of two TB vaccines-- the currently available BCG vaccine and an investigational vaccine, H4:IC31--in the New England Journal of Medicine (NEJM).

12 Jul 2018

Study: Hepatitis C vaccine could drastically reduce transmission among injecting drug users

Among the most serious consequences of the opioid epidemic is the spread of hepatitis C among injecting drug users.

12 Jul 2018

New 3D model of 1918 H1 pandemic influenza virus could benefit VLP vaccine projects

Virus-like particles are protein-based structures that mimic viruses and bind to antibodies. Because VLPs are not infectious, they show considerable promise as vaccine platforms for many viral diseases, including influenza.

12 Jul 2018

Preventative HIV vaccines induce robust, comparable immune responses in humans and monkeys

More than three decades after the identification of the human immunodeficiency virus, scientists are still working to develop a preventative vaccine that could finally put an end to the epidemic for which there are nearly two million new infections each year.

9 Jul 2018

Step towards an HIV/AIDS vaccine

There has been a four decades long challenge to develop a vaccine against the deadly HIV virus that causes AIDS. Last Saturday the research bore fruit when a team of scientists announced that a trial drug has shown immune response in humans and also protected laboratory monkeys from HIV infection.

9 Jul 2018

Vaccine News and Research

Latest Vaccine News and Research

Researchers report first randomized trial results of 'kick and kill' approach to treat HIV

New study provides important clues to developing more effective Ebola vaccines

Outrage over China vaccines scandal

MOF vaccines could increase access to immunization and reduce the risk of global pandemics

Studies highlight issues regarding black lung, opioid overdose, police violence and more

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

New vaccine could protect unborn babies from Zika virus

Researchers design proteins that can self-assemble into complex structures

Researchers create vaccine that protects against malaria in mouse models

Retooled vaccine raises hopes as a lower-cost treatment for Type 1 diabetes

Researchers develop novel approach to bridge gap in cell-free systems

Researchers decipher key component behind rising epidemic of pathogens in West Africa

Aeras announces publication of Phase 2 results of two TB vaccines

Study: Hepatitis C vaccine could drastically reduce transmission among injecting drug users

New 3D model of 1918 H1 pandemic influenza virus could benefit VLP vaccine projects

Preventative HIV vaccines induce robust, comparable immune responses in humans and monkeys

Step towards an HIV/AIDS vaccine

Research suggests new target for malaria vaccine

Sylvester dermatologist uses HPV vaccine to treat patient with squamous cell tumors

Simple, accurate and reproducible assay to measure antibodies against malaria

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Newsletters you may be interested in